Introduction
Glioma is the most common malignant neoplasm afflicting the central nervous system (CNS). Because a glioma develops invasively in intracranial CNS tissues, the feasibility of total surgical resection decreases as tumor becomes larger and more invasive. Thus, after surgical resection, supplemental treatments are performed, including irradiation, anti-cancer chemotherapy, and administration of cytokines such as interferon-␥. Despite these treatments, the prognosis for a malignant glioma remains far from satisfactory. 1 In 1992, a new treatment method for glioma emerged: gene therapy using 'suicide' gene, herpes symplex virus thymidine kinase (HSVtk), in combination with a prodrug, ganciclovir. 2 This HSVtk gene was transferred to rat glioma tissue by retroviral packaging PA317 cells, which produce non-proliferative retroviruses integrating HSVtk gene in their genome. When ganciclovir was administered to the rats, gliomas regressed completely from the rat brain. Following this experiment, gene therapy using the HSVtk-integrated retrovirus-producing packaging cells has been applied to clinical studies on the treatment of human gliomas and glioblastomas in the United States sequence has been removed by Cre recombinase at a pair of loxP sites. We used seven human glioma/glioblastoma cell lines: U251, KG-1C, NGM5, U87 MG, LN-Z308, NP-2 and T98G. Of these, nestin was expressed highly in U251 and KG-1C, less in NGM5, and undetectably in the other four lines. With the use of the two adenovirus vectors, we found X-gal staining and high nestin regulator-promoted ␤-galactosidase activities in four of the seven glioma/glioblastoma cell lines. Staining was strong in U251, KG-1C and NGM5, and less in U87 MG. LacZ expression was nearly undetectable in the non-glioma cell line, HeLa, but a little in COS-7. The adenovirus double-infection method, which uses a nestin regulator, is applicable for glioma/glioblastoma-specific expression. Gene Therapy (2000) 7, 686-693. and France. 3, 4 The clinical studies performed by these two groups were evaluated as safe and although further technical improvements are needed, both trials detected an antitumor effect in some patients. Retroviral gene expression requires cell division for the chromosomal integration of the retroviral genome; therefore, a retroviral vector would appear to be ideal for selective gene transfer to neoplastic dividing cells. However, retroviruses do not present strong infectivity; thus, they exhibit low transduction activity to target cells. In contrast, an adenovirus vector is noted for much more efficient transduction activity. 5, 6 Treatment with the adenoviral HSVtk gene-transfer method appears to be successful to rat C 6 glioma tumors implanted in the brains of athymic nude mice. 7 Adenoviral gene expression does not require cell division, and its DNA replication is extrachromosomal. The adenovirus vectors with cytocidal genes may cause cytotoxic effects not only to cancer cells but also to normal tissues. Ideally, when using an adenovirus expression system in gene therapy for gliomas, a gliomaspecific gene-expression device would prevent damage to normal brain tissues. For this purpose, several promoters, myelin basic protein (MBP) and glia fibrillary acidic protein (GFAP) in particular, have been examined for their tissue specificity in the brain. [8] [9] [10] The GFAP promoter appears to be especially promising for use in gliomaspecific expression; however, because GFAP is expressed in normal glial tissues, 11, 12 its use for promoter-selected gene expression may cause cell damage to these tissues.
After an extensive search for glioma-specific expression, we noted that nestin, an intermediate filament protein, is expressed in neuroepithelial stem cells and disappears upon differentiation to neuronal and glial fates. 13, 14 In normal brain tissue, this protein is expressed only in occasional endothelial cells. 15 In glioma tissues, nestin immunoreactivity occurs only in tumor cells, and the quantity of nestin produced increases as the grade of glioma becomes more malignant toward glioblastoma. 15 Furthermore, based on a study of transgenic mice that express lacZ gene under the control of the nestin gene's second intron, 16 we know that the second intron is essential for the fetal stage-specific expression of nestin in CNS progenitor cells. In short, nestin is an oncofetal protein, and using the regulatory promoter/enhancer regions of its second intron may be suitable for glioma/ glioblastoma-specific gene expression.
Another problem with using tissue-specific promoter/enhancers is their generally low expression activity. 9 Recently, Sato et al developed a double-adenoviral infection method that enhances cell/tissue-specific gene expression approximately 50-fold, using two adenovirus vectors with the Cre/loxP switching system. 17, 18 This system greatly enhances low-level gene expression in a cell/tissue-specific manner. In this study, we generated a double-adenoviral infection method for glialtumor-specific, enhanced gene expression with the use of a nestin gene regulatory element and a Cre/loxP on-off system.
Results

Construction of recombinant adenovirus vectors
To construct a nestin-gene-promoted adenoviral expression system, we cloned the rat nestin gene, including the 5Ј upstream region and the second intron. We made a chimeric regulator by combining the 1.8-kb second intron, containing part of the flanking regions of exon 1 and exon 2, with the 2.1-kb 5Ј upstream basic promoter region (2iNP). In the same fashion, we made another chimeric promoter/enhancer DNA by combining the nestin second intron and the 760-bp herpes simplex virus thymidine kinase (HSVtk) basic promoter (2iTK). The second intron of both rat and human nestin genes is reportedly similarly active in directing fetal-stage-specific gene expression to CNS progenitor cells in transgenic mice. 16 Following generation of the chimeric regulator unit, we inserted recombinase Cre DNA (Figure 1a , Ax2iNPNCre). Recombinase Cre is a 38-kDa protein derived from bacteriophage P1, and recombines DNA by excising a DNA fragment that is flanked by a pair of loxP sites, forming the Cre-specific recognition sequence of 34 nucleotides. Cre cleaves easily at loxP sites. Thus, glioma cells expressing only small amounts of the nestin gene produce sufficient recombinase Cre to cleave loxP sites under the control of the nestin chimeric regulator. The recognition sites of recombinase Cre (loxP) were placed at both ends of a stuffer DNA sequence, and this stuffer was placed between the CAG promoter and lacZ gene (AxCALNLNZK, Figure 1b) . The CAG promoter, derived from a chicken ␤-actin promoter plus the cytomegalovirus immediate-early region enhancer, is one of the strongest promoters in eukaryotic cells. 19 The stuffer DNA is made from a neomycin-resistant gene and a polyGene Therapy adenylation (polyA) site, and interrupts the CAGpromoted expression of lacZ by its polyA sequence. 18 Thus, when recombinase Cre is expressed in glioma cells, stuffer DNA is removed by the Cre-specific cleavage of loxP sites at both ends of the stuffer DNA, and lacZ expression is activated under the control of the CAG promoter. As a positive control, we used CAG-promoted lacZ expression integrated in an adenovirus vector (AxCALacZ, Figure 1c ).
Selectivity of the adenovirus double-infection method
We used seven human glioma/glioblastoma cell lines, U251, KG-1C, NGM5, U-87 MG, LN-Z308, NP-2 and T98G; and two non-glioma cell lines, HeLa and COS-7. Of the seven glioma/glioblastoma cell lines, KG-1C and NGM5 cells grew slower than the other five, and of those five, their growth-rate order at day 6 was T98GϾU251ϾU87 MGϾNP-2ϾLN-Z308, but the order of T98G dropped down at day 8 (data not shown). The growth rate of each cell line did not correlate with its original tumor type, glioma or glioblastoma.
We initially evaluated the efficiency of gene expression using a positive control adenoviral vector, AxCALacZ, whose expression is controlled by the strong CAG promoter ( Figure 1c ). For each cell line, we infected this adenovirus with three multiplicities of infection (MOI): 10, 20 and 50. At an MOI of 10, 90-100% of the U251 cells were stained blue by X-Gal and the degree of staining increased with the MOI number ( Figure 2) .
We next examined the selectivity of the two adenoviruses, Ax2iNPNCre and AxCALNLNZK (Figure 1a and b), using the seven glioma/glioblastoma and two nonglioma/glioblastome cell lines. At an MOI of 20, neither of the other two adenoviral constructs yielded blue staining in any cell line (Figure 3) . Thus, the AxCALNLNZK containing the lacZ gene was not leaky in the absence of the nestin gene regulator.
Nestin expression by Northern blot
We used Northern blot analysis to examine the expression of the nestin gene in each cell line. Two cell lines, U251 and KG-1C, displayed a thick blotting band, that of NGM5 was less thick. The other four cell lines, U-87 MG, NP-2, LN-Z308 and T98G, presented nearly undetectable blotting (Figure 4, upper panel) . Likewise, two non-glioma cell lines, COS-7 and HeLa, did not yield a distinct blotting band. House-keeping expression was examined with glyceraldehyde-3-phosphate dephydorogenase (GAPDH), and its expression was similar among the nine cell lines (Figure 4 , lower panel). Thus, high nestin expression was observed in some glioma/ glioblastoma cell lines, such as U251 and KG-1C.
Nestin expression by RT-PCR
By Northern blot analysis, we could not neglect the negative nestin expression in U87 MG, NP-2, LN-Z308, T98G, COS-7 and HeLa cells. To confirm nestin expression in these cells, we used a reverse transcription (RT)-PCR method. As a positive control, we used RNA from U251 cells. In Figure 5 , we detected a definite PCR band from U87 MG cells, which corresponded to a thick band from U251 cells in size, but not from COS-7 cells. By increasing PCR cycle numbers, we found a faint band from the other three glioma/glioblastoma cell lines NP-2, LN-Z308 and T98G. Thus, glioma/glioblastoma cells appear to express nestin mRNA more or less in amounts.
LacZ expression by the double adenoviral infection
In U251 and KG-1C, which presented relatively higher nestin expression, the two recombinant adenovirus vec- tors, Ax2iNPNCre and AxCALNLNZK, yielded a strong blue staining, as seen by the positive control vector AxCALacZ ( Figure 6, U251 and KG-1C) . In NGM5, which shows lower nestin gene expression, staining was similarly strong (Figure 6, NGM5) . In four glioma/ glioblastoma cell lines, nestin expression was nearly undetectable: U-87 MG showed a relatively strong X-gal staining by the two adenovirus vectors (Figure 6 , U-87 MG); LN-Z308 was stained well with the positive control vector, AxCALacZ, but not with the two-virus method, indicating that the nestin regulator did not work in this cell line; NP-2 and T98G were relatively resistant even to the positive control vector AxCALacZ, and so were also resistant to the two-virus infection method ( Figure 6 , NP-2 and T98G). The non-glioma cell lines, COS-7 and HeLa, were positively stained by the control vector AxCALacZ. Although HeLa was negative for the two-virus method, COS-7 showed a little scattering staining ( Figure 6 , COS-7 and HeLa).
We further measured ␤-galactosidase enzyme activities in all the cell lines to confirm the X-gal histochemistry analysis shown in Figure 6 ( Table 1) . By a positive control vector AxCALacZ (MOI = 20), the activity was highest in U251, and lowest in NP-2, ranging from 6317 to 101 nanounits per cell. Thus, even by a ubiquitously expressing vector, the activity varied quite widely. By the selectively expressing vectors, Ax2iNPNCre and AxCALNLNZK, the activity was highest in U251, followed by NGM-5, U87 MG, COS-7, KG-1C, HeLa, LN-Z308, T98G and NP-2. Because non-glioma/glioblastoma cell line COS-7 contains relatively high enzyme activity, we obtained a relative ratio of the nestin promotedactivity over the ␤-actin-promoted activity. The three glioma/glioblastoma cell lines U-251, KG-1C and NGM-5 displayed a high ratio of over 0.5, and U-87 MG was 0.32. The other three glioma/glioblastoma cell lines NP-2, LN-Z308, and T98G showed below 0.1. However, COS-7 presented a relatively high ratio of 0.23. Although we could not note nestin expression in COS-7 by Nothern blot and RT-PCR, we obtained positive X-gal staining and relatively high ␤-galactosidase enzyme activity. The nestin promoter we used may contain regions which are activated in a non-tissue-specific manner. The glioma/ glioblastoma-specific promoter elements should be narrowed down in more detail.
Use of a HSV thymidine kinase gene as a basic promoter
We constructed Ax2iTKNCre in which the second nestin intron was fused to an HSVtk basic promoter. We compared this HSVtk promoter 2iTK with the nestin regulator 2iNP. As shown in Figure 7 , the infection of Ax2iTKNCre + AxCALNLNZK presented strong X-gal staining similar to that of Ax2iNPNCre + AxCALNLNZK. However, the use of TK-containing adenovirus vector yielded stronger X-gal staining than did the infection of the NP-containing vector in the two non-glioma/glioblastoma cell lines COS-7 and HeLa. Thus, the virus containing TK promoter provided less specificity than the virus containing the nestin basic promoter NP.
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Figure 4 Northern blot analysis of nestin expression. Upper panel, nestin blotting; lower panel, GAPDH blotting. Arrowheads indicate 28S and 18S ribosomal RNAs.
Figure 5 RT-PCR analysis of nestin expression. Left three lanes, RT-PCR products using nestin primers (550 bp); right three lanes, RT-PCR products using GAPDH primers (450 bp). A 550 bp band was detected faintly in U87 MG cells and thickly in U251 cells, but not in COS-7 cells. GAPDH mRNA was used as a calibration standard of RT-PCR for each cell line.
Discussion
This study demonstrates that a chimeric nestin regulator consisting of the 5Ј upstream region and the second intron of the nestin gene promotes glioma/glioblastomaspecific expression in four of the seven human glioma/glioblastoma cell lines tested. This cell typespecific expression was attained by use of the adenovirus double-infection method with a Cre-loxP on/off switching system. Enhancement was typically observed in U-87 MG cells whose nestin expression was almost undetectable with the Northern blot technique (Figure 4) .
Cell/tissue-specific elimination of tumor cells has been attempted by using such cell/tissue-specific promoters as alpha-fetoprotein promoter in hepatocellular carcinoma, 20 and carcinoembryonic antigen promoter in gastric cancer. 21 The GFAP promoter is reportedly effective for glioma/glioblastoma-specific expression.
9, 10 Chen et al 9 constructed double adenoviral methods: one includes three tandem repeats of a GFAP enhancer region and a cytomegalovirus (CMV) basal promoter placed in front of a tetracyclin-responsive activator gene (tTA); the other includes a tetracyclin operator gene (tetO) in front of the lacZ gene. Under the control of the GFAP enhancer, the tTA is expressed, followed by activation of tetO, which directs lacZ expression in a cascade fashion. The authors used three repeats of the GFAP enhancer because GFAP expression in glioma/glioblastoma is known to be weak. In this sense, the use of the two-adenovirus method is based on the same idea. GFAP is the major protein of glial intermediate filaments in differentiated astrocytes; 11 thus, GFAP promoter-dependent expression is observed in normal glial cells. Furthermore, using a basal promoter for CMV expression may lessen the specificity of GFAP promoter. In this study the use of basal thymidine promoter (760 bp) in combination with the nestin second intron resulted in leaky expression in glioma/ glioblastoma cells ( Figure 7) . Nestin expression appears to be specific to neoplastic brain tissue. Dahlstrand et al 15 reported nestin staining in glioblastoma, anaplastic astrocytoma, oligodendroglioma, and primitive neuroectodermal tumors. They demonstrated the presence of nestin in all 15 glioblastoma tissues and found that the frequency of nestin-positive tumor cells is at most 50% of total tumor cells examined in any tumor tissue, and that tumor cells strongly expressing nestin are often located close to blood vessels. In contrast, they found no nestin protein in normal brain tissue, except for an occasional presence in endothelial tissues. Thus, although Dahlstrand et al found nestinpositive tumor cells in all 15 glioblastomas, some glioma/glioblastoma cell lines in this study do not express high levels of nestin; nestin-negative cell lines may have been derived from nestin-negative tumor cells in glioma/glioblastoma tissues. However, even though not all tumor cells express nestin in glioma/glioblastoma tissues, the nestin regulator-mediated elimination of tumor cells appears to be ideal for the gene therapy of gliomas and glioblastomas when we take into consideration the bystander elimination effect of prodrugs such as gancyclovier on neighboring tumor cells. 22 LacZ expression promoted by the nestin gene regulator was detected in the three nestin mRNA-positive cell lines: U251, KG-1C and NGM5. These three cell lines also displayed a high nestin regulator-promoted ␤-galactosidase activity (Table 1 ). In the four cell lines with nearly undetectable nestin expression, U87 MG stained positive for lacZ by the double-infection method. Although U87 MG was negative in nestin expression by Northern blot, this cell line yielded a positive DNA band by RT-PCR. Furthermore, U-87 MG showed a high nestin regulatorpromoted ␤-galactosidase activity. Thus, RT-PCR appears to provide more reliable data for nestin-promoter-directed effects. NP-2 and T98G appeared to be relatively resistant to adenovirus infection, because the CAG-promoted lacZ expression was even less efficient by both X-Gal staining and ␤-galactosidase activity ( Figure  5 and Table 1 , NP-2 and T98G). Adenovirus requires a fiber receptor, such as coxsackie/adenovirus receptor, and ␣v integrins to infect the target cells. 23 Recently, Yoshida et al 24 generated a fiber-mutant recombinant adenovirus by inserting a stretch of 20 lysine residues at the carboxyl terminus of the adenoviral fiber protein. The infectivity of this fiber-mutant adenovirus vector is 10 times more efficient than that of the non-mutant control adenovirus vector. Using this fiber-mutant adenovirus vector should improve the infection efficiency of NP-2 and T98G.
Glioma cells has been eliminated with the 'suicide' gene, HSVtk. 22 A number of other effective killer genes have been reported, including diphtheria toxin and apoptosis-inducing genes, such as p53, FADD, and E2F-1.
25-28 Among these, diphtheria toxin combined with transferrin has proven effective in patients with malignant brain tumors;
25 the diphtheria toxin-transferrin conjugate is internalized via transferrin receptors that are highly expressed in rapidly dividing cells but not in normal neuronal and glial tissues. We are currently selecting 'suicide' genes, including the diphtheria toxin and prodrug-activating genes, which will be expressed under the control of nestin gene regulator.
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Materials and methods
Cell lines
We used seven human glioma and glioblastoma cell lines: U251 glioma cell (RCB 0461, Riken Gene Bank, Tsukuba, Japan), KG-1C glioma cell (RCB 0270), U87 MG glioblastoma (ATCC HTB 14), NGM5 glioblastoma cell and LN318 glioblastoma cell (gifts from Dr J Adachi, Saitama Medical School, Moroyama, Japan), NP-2 glioblastoma cell (a gift from Dr H Hoshino, Department of Hygine, Gunma University School of Medicine), and T98G glioblastoma cell (ATCC CRL 1690); and two non-glioma cell lines, HeLa (ATCC CRL 2) and COS-7 (ATCC CRL 1651). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Sigma, St Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS; GIBCO, Grand Island, NY, USA) at 37°C in 5% CO 2 . Human embryonal kidney (HEK) 293 cells (ATCC, CRL 1573) were cultured in MEM supplemented with 10% FBS. For drawing growth curves for each cell line, cells were counted using a hemocytometer after cells were seeded at an initial concentration of 2.0 × 10 4 cells per well.
Construction of a nestin regulator-promoted lacZ expression system using adenovirus vectors We cloned the 8-kb rat nestin genomic DNA, including the 5Ј upstream region and the second intron, from a rat genomic DNA library (GIBCO/BRL, Rockville, MD, USA), using oligonucleotides based on previously published rat nestin cDNA sequence. 13 The nestin gene regulator was generated according to the previously published results of Zimmerman et al. 14 To make the chimeric regulator, we cut out the 2.1-kb nestin promoter/enhancer by XmnI; this DNA fragment contains the TATA box but not exon 1. The 1.8-kb BstYI-cut genomic DNA fragment containing the nestin second intron was placed before this 2.1-kb 5Ј upstream sequence (2iNP). Likewise, the 1.8-kb second intron was placed before the760 bp 5Ј upstream sequence of the HSVtk gene (2iTKP). These nestin 'regulators' were placed before the Cre recombinase sequence in a cosmid pAxAwNCre (Riken Gene Bank). 18 We modified the Cre for nuclear localization by attaching the nuclear localization signal (NLS) from SV40 T antigen (NCre). 17, 18 Two cosmids, pAx2iNPNCre and pAx2iTKPNCre, were subjected to a homologous recombination with the EcoT22I-digested DNA-terminal protein complex of Ad5-dlX 29 in HEK 293 cells. Because the 293 cells are integrated with the adenoviral E1A region, E1A-deleted adenoviral recombinant DNA can propagate in the cells. The day after the homologous recombination was performed, the 293 cells were spread to 96-well culture plates, and cultured for 2 weeks. The culture medium was harvested as a virus stock from wells that contained lysed cells. After using restriction enzymes to comfirm the presence of either the nestin regulator sequence or the lacZ sequence, the adenoviruses (Ax2iNPNCre, Figure  1a ; AxCALNLNZK, Figure 1b) were increased for purification by velocity density gradient centrifugation. 30 A virus titer was determined using the 293 cells, and the MOI was calculated for each infection experiment. 31 The target virus, AxCALNLNZ, was made as described previously, 18 and was added K, the initial of Kurihara, to the end of the virus acronym. This virus contains CAG promoter, a stuffer sequence consisting of a neomycin-resistant gene plus a SV40 T antigen polyA site, a lacZ sequence tagged with SV40 NLS, and a ␤-globin polyA signal (Figure 1c ).
Northern blot
Total RNA was isolated from each cell line using the TRIzol reagent (Life Technologies, Gaithersburg, MD, USA). Total RNA (30 g per slot) was denatured with 6.3% formaldehyde/50% formamide, electrophoresed on a 1.0% agarose gel containing 6.6% formaldehyde, then blotted to a nylon membrane (Amersham Life Science, Tokyo, Japan). Hybridization was performed with a probe of rat nestin gene DNA fragment (550 bp), labeled with ␣-32 P deoxyCTP by the random priming procedure. A GAPDH probe was used as a control. The membrane was exposed to a radiographic film (Eastman Kodak, Rochester, NY, USA) with an intensifying screen at −80°C.
RT-PCR
Following the isolation of total RNA, mRNA was purified with the oligo dT cellulose Micro-Fast Track (Invitrogen, Carlsbad, CA, USA) in U251, U87 MG and COS-7 cells. First strand cDNA was synthesized from each mRNA fraction using an oligo dT adaptor primer. Then, PCR amplification was performed for human nestin (5Ј-GGGACAGAGTTCTCCGAGCT-3Ј, 5Ј-GAAGCCAGGA-CAGCAGGATC-3Ј) and for glyceraldehyde phosphodehydrogenase (GAPDH) as an internal control. cDNA products of the RT reaction were denatured at 94°C for 5 min, followed by a 35 cycle-PCR reaction (94°C for 60 s, 67°C for 60 s, and 72°C for 60 s). PCR products were separated by an agarose gel.
Detection of lacZ gene expression
Cells were seeded on to a 24-well culture plate at a concentration of approximately 1.0 × 10 5 cells per well. The next day, Ax2iNPNCre and AxCALNLZK were coinfected to these cells with three different MOIs; as a positive control, AxCALacZ was infected with the same MOIs. Adenovirus infection was performed by incubating virus stock solution with culture cells at 37°C for 1 h, then the culture medium was replaced for fresh one. Three days after infection, cells were fixed with 0.5% glutaraldehyde for X-gal staining. X-gal stained cells were evaluated by a planimeter.
For measurement of ␤-galactosidase activity, we used a ␤-Gal Assay Kit (Invitrogen). Cells were harvested in the lysis buffer supplied with the kit at day 3 after adenovirus infection. The cell lysate was then subjected to a color reaction with O-nitrophenyl-␤-galactopyranoside. 32 The color density was measured at absorbance 415 nm using an automated microplate reader.
